Total serum IgE level in COPD exacerbations


Original Article

Author Details : Anbarasan Thiru, Srivastava G N, Mishra J K*, Pulkit Gupta, Bhupendra Kumar Rajak

Volume : 7, Issue : 3, Year : 2020

Article Page : 95-99

https://doi.org/10.18231/j.jchm.2020.022



Suggest article by email

Get Permission

Abstract

Background: COPD exacerbations were diagnosed based on the clinical parameters only. Till now we
were unable to find out a reliable blood based biomarker. Serum IgE is one of the measurements of airway
inflammation which is well established in asthma, it’s role in COPD not studied adequately.
Materials and Methods: This is a cross sectional study conducted in a tertiary care center. This study
included 75 COPD patients who were admitted in our hospital for exacerbations. Exacerbations defined by
the GOLD report 2018. Complete history & Total serum IgE levels were obtained from all patients during
admission, pulmonary function test has been done at the time of discharge and results were analyzed.
Results: In our study the mean value of serum IgE is 416.75 IU/L. Patients who had elevated serum IgE
(>100 IU/L) levels were 55 (73.3%). FEV1/FVC ratio significantly high in elevated IgE group (0.580.09
in elevated IgE vs 0.490.10 in IgE not elevated, p<0> more in elevated IgE group (13.7%+185ml in elevated IgE vs 6.4%+73ml in IgE not elevated, p=0.001).
IgE elevated patients have seasonal variation history, Biomass exposure history. They had more Asthma
COPD Overlap features than IgE not elevated group (p=0.001).
Conclusion: COPD patients can have elevated serum IgE levels during exacerbations. IgE may play an
important role in pathogenesis of COPD and can be used as a biomarker for COPD Exacerbations.
Key message: Serum total IgE can be used as a biomarker in COPD exacerbations. This can be used as a
new therapeutic target for the same.

Keywords: Humans, Chronic obstructive pulmonary, Disease, Biomarkers, Immunoglobulin E, Asthma.


How to cite : Thiru A , Srivastava G N, Mishra J K, Gupta P , Rajak B K , Total serum IgE level in COPD exacerbations. J Community Health Manag 2020;7(3):95-99


This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.







View Article

PDF File   Full Text Article


Copyright permission

Get article permission for commercial use

Downlaod

PDF File   XML File   ePub File


Digital Object Identifier (DOI)

Article DOI

https://doi.org/10.18231/j.jchm.2020.022


Article Metrics






Article Access statistics

Viewed: 1624

PDF Downloaded: 496